Hong Kong market could open cash flood gates for U.S. biotechs

(Reuters) - When U.S. biotech startup Sorrento Therapeutics named ex-Lehman Brothers executive Jiong Shao as its new finance chief about two months ago, it was widely seen as a move driven by his background in raising capital for Alibaba and Tencent.

Read more...
Positive 0 LOL 0 Interesting 0 Sad 0 Revolting 0 Fake 0

See also

10 Things to Know for Today

Among 10 Things to Know: Trump warns Iran not to threaten US or it will face 'end'; Google says services on Huawei phone still will function; EPA shifts more environmental enforcement to states

0 0

Whoops, looks like something went wrong.